VIA Pharmaceuticals, Inc.
OTC: VIAP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Thomas Quertermous
- Employees
- 6
- Headquarters
- San Francisco, United States
- IPO year
- 2007
- Market cap
- $10.3K
- Website
- http://www.viapharmaceuticals.com
Loading VIAP…
Loading profile data…Frequently asked questions about VIAP
What does VIA Pharmaceuticals, Inc. (VIAP) do?
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated chole...
Where does VIAP trade?
VIA Pharmaceuticals, Inc. (VIAP) trades on the Other OTC.
What sector is VIAP in?
VIA Pharmaceuticals, Inc. (VIAP) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of VIA Pharmaceuticals, Inc.?
Thomas Quertermous is the chief executive officer of VIA Pharmaceuticals, Inc. (VIAP).
Where is VIA Pharmaceuticals, Inc. headquartered?
VIA Pharmaceuticals, Inc. is headquartered in United States.
Does VIAP pay a dividend?
VIA Pharmaceuticals, Inc. (VIAP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIAP go public?
VIA Pharmaceuticals, Inc. (VIAP) completed its initial public offering in 2007.